Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Principal Scientific Adviser to GoI reviews progress to transform India regulatory ecosystem for medical products

Written By Ruchika Sharma22 Aug 2024 11:30 AM IST

New Delhi: Prof. Ajay Kumar Sood, Principal Scientific Adviser (PSA) to the Government of India took a meeting to review the progress made...

Daiichi Sankyo, AstraZeneca Enhertu gets USFDA breakthrough therapy designation for certain patients with HER2 low or HER2 ultralow metastatic breast cancer

Written By Ruchika Sharma21 Aug 2024 3:37 PM IST

Tokyo: ENHERTU (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the U.S. for the treatment of unresectable...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

JnJ chemotherapy free lung cancer treatment Rybrevant plus Lazcluze gets USFDA okay

Written By Ruchika Sharma21 Aug 2024 12:30 PM IST

New Jersey: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT (amivantamab-vmjw) plus...

NPPA Finally Allows GSK to Discontinue Grisovin FP

GSK secures USFDA Breakthrough Therapy Designation for GSK5764227 for extensive stage small cell lung cancer

Written By Ruchika Sharma21 Aug 2024 11:30 AM IST

London: GSK plc has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for GSK5764227 (GSK’227),...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

Johnson & Johnson to acquire V-Wave

Written By Ruchika Sharma21 Aug 2024 10:00 AM IST

New Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held...

Marksans Pharma Gets USFDA Nod for Generic Tessalon Capsules

USFDA issues EIR for Marksans Pharma Goa facility

Written By Ruchika Sharma20 Aug 2024 4:45 PM IST

Mumbai: Marksans Pharma has announced that the US Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR) for...

Groundbreaking digital platforms, Indian Pharmacopoeia online portal, Adverse Drug Reaction Monitoring System software launched at First Policy Makers' Forum

Written By Ruchika Sharma20 Aug 2024 12:30 PM IST

New Delhi: Union Minister of Health and Family Welfare & Chemicals and Fertilizers, Shri J.P. Nadda inaugurated the 'First Policy Makers'...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

Strides Pharma Science arm gets USFDA EIR for Alathur facility

Written By Ruchika Sharma20 Aug 2024 11:25 AM IST

Bengaluru: Strides Alathur Private Limited, a wholly-owned subsidiary of Strides Pharma Science Limited has received an Establishment Inspection...

AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus

AstraZeneca gets USD 107 million Pfizer verdict overturned in US cancer drug patent fight

Written By Ruchika Sharma19 Aug 2024 4:45 PM IST

Cambridge: AstraZeneca has convinced a Delaware federal judge to throw out a jury's decision that the company owes USD 107.5 million for...

USFDA grants marketing authorization for First To Know Syphilis Test for OTC use

Written By Ruchika Sharma19 Aug 2024 4:00 PM IST

Springdale: NOWDiagnostics, Inc., a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, has announced that the U.S....

DCGI Told to Act Against Unapproved Antibiotic FDCs

India's medicine, antibiotics exports gaining share in US, Italian markets: Govt

Written By Ruchika Sharma18 Aug 2024 1:15 PM IST

New Delhi: As the government emphasizes enhancing domestic pharmaceutical manufacturing, India's exports of medicines and antibiotics have begun...

Imfinzi, Lynparza combo approved in EU for mismatch repair proficient advanced or recurrent endometrial cancer: AstraZeneca

Written By Ruchika Sharma18 Aug 2024 10:00 AM IST

Cambridge: AstraZeneca's Imfinzi (durvalumab) and Lynparza (olaparib) have been approved in the European Union (EU) as treatment for certain...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok